Oritavancin

#	Item
11	PDF Document Add to Reading List Source URL: media.integratir.com Language: English - Date: 2007-10-05 18:20:05 Lactobacillales Bacterial diseases Antibiotics Glycopeptide antibiotics Oritavancin Targanta Therapeutics Corporation Vancomycin Linezolid Staphylococcus aureus Bacteria Gram-positive bacteria Eli Lilly and Company
12	PDF Document Add to Reading List Source URL: media.integratir.com Language: English - Date: 2007-10-05 18:13:34 Bacteria Anthrax attacks Biological weapons Bacillaceae Oritavancin Anthrax Targanta Therapeutics Corporation Bacillus anthracis United States Army Medical Research Institute of Infectious Diseases Biology Eli Lilly and Company Medicine
13	Interactions of oritavancin, a new lipoglycopeptide derived from vancomycin, with phospholipid bilayers: Effect on membrane permeability and nanoscale lipid membrane organization Add to Reading List Source URL: www.farm.ucl.ac.be Language: English - Date: 2009-10-27 07:38:44
14	PDF Document Add to Reading List Source URL: media.integratir.com Language: English - Date: 2007-10-05 18:21:32 Microbiology Glycopeptide antibiotics Oritavancin Gram-positive bacteria Diarrhea Gut flora Targanta Therapeutics Corporation Clostridium difficile Vancomycin Eli Lilly and Company Bacteria Biology